Company Description

Sift Biosciences is building a proprietary platform that combines AI, metagenomics, and high-throughput T-cell screening to discover molecules that drastically amplify immune responses, unlocking targeted, effective, and safe treatment for cancers and autoimmune diseases where current therapies fall short.